patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Off-patent semaglutide in 2026: the

Understanding the Role of Muscle Loss westendchiros Sep 15, 2025 3 min read Ozempic (semaglutide) has been life-changing for many people managing type 2 diabetes and obesity

Rheumatoid arthritis requires prompt rheumatology referral and disease-modifying drugs such as methotrexate, with biological therapies for refractory cases

The result: habit work that feels like a game, not a chore, with tools built around GLP-1 care and safety

Addressing depression and obesity simultaneously, with two medications that work through complementary mechanisms and do not interfere with each other pharmacologically, represents one of the more elegant treatment combinations available today

Pairing psyllium with balanced meals and mindful movement helps maintain the natural rhythm of GLP-1, supporting both metabolic health and long-term weight balance